LP
SRNE

LMR Partners’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

LMR Partners’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-88,263
Closed -$177K – 596
2017
Q2 		$177K Buy
+88,263
New +$172K 0.01% 537
2014
Q2 		– Sell
-30,206
Closed -$387K – 593
2014
Q1 		$387K Buy
+30,206
New +$334K 0.05% 162

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

LMR Partners's SRNE Position: Q3 2017 in Review

LMR Partners sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2017, closing a stake of 88,263 shares — an estimated $177K sold.

LMR Partners first reported a position in SRNE in Q1 2014 and held it in 2 quarters. The position peaked at $387K in Q1 2014. 37 funds tracked by Wall St. Rank hold SRNE as of Q3 2017.

  • LMR Partners reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
  • LMR Partners sold 88,263 Sorrento Therapeutics, Inc. shares in Q3 2017, an estimated $177K.
  • LMR Partners first reported a position in Sorrento Therapeutics, Inc. in Q1 2014 and held it in 2 quarters.
  • LMR Partners's Sorrento Therapeutics, Inc. position peaked at $387K in Q1 2014.
  • 37 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2017.

Based on LMR Partners's 13F filing for Q3 2017, filed 9 Nov 2017.